Skip to main content
. 2023 Feb 1;11(2):328. doi: 10.3390/vaccines11020328

Table 2.

Sub-group analysis within Mw + ChAdOx1 group.

Sub-Group SARS-CoV-2 Infection No SARS-CoV-2 Infection p-Value
Mw + ChAdOx1 both doses 2 22 0.22
Mw + ChAdOx1 single dose 0 26